首页> 外文学位 >Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies

【24h】

Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies

机译：I阶段研究促进酶活性化合物-1（PAC-1）治疗晚期恶性肿瘤

获取原文

获取原文并翻译 | 示例

页面导航

著录项
相似文献
相关主题

著录项

作者
Danciu, Oana.;
展开▼
作者单位

University of Illinois at Chicago.;

展开▼
授予单位 University of Illinois at Chicago.;
学科
学位 M.S.
年度 2018
页码 87 p.
总页数 87
原文格式 PDF
正文语种 eng
中图分类 AAI10956819;
关键词
Phase i; Tumor;

机译：阶段I;瘤;
入库时间 2022-08-17 12:01:00

相似文献

外文文献
中文文献
专利

1. ERO1α-dependent endoplasmic reticulum–mitochondrial calcium flux contributes to ER stress and mitochondrial permeabilization by procaspase-activating compound-1 (PAC-1) [J] . M Seervi, P K Sobhan, J Joseph, Cell death & disease. . 2013,第12期

机译：依赖ERO1 α的内质网-线粒体钙通量通过procaspase-activated compound-1（PAC-1）促进ER应激和线粒体通透性
2. A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies [J] . PishvaianM.J., MarshallJ.L., WagnerA.J., Cancer: A Journal of the American Cancer Society . 2012,第21期

机译：埃法他他酮（口服过氧化物酶体增殖物激活受体γ激动剂）的1期研究，用于晚期恶性肿瘤患者
3. Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies. [J] . Weiss GJ, Infante JR, Chiorean EG, Clinical cancer research: an official journal of the American Association for Cancer Research . 2011,第9期

机译：TH-302（一种缺氧激活的前药）在晚期实体恶性肿瘤患者中的安全性，耐受性和药代动力学的1期研究。
4. Pilot scale Study on Advanced Treatment of Coking Wastewater with Biological Activated Carbon Technology [C] . Jin Li, Guanghua Wang, Wenbing Li International Conference on Energy, Environment and Sustainable Development . 2015

机译：生物活性炭技术焦化废水先进治疗试验规模研究
5. Activation of Apoptotic Procaspases [D] . Zorn, Julie Anne 2012

机译：凋亡蛋白酶的激活
6. ACTR-63. PHASE I DOSE ESCALATION STUDY OF PROCASPASE ACTIVATING COMPOUND-1 (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE IN PATIENTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA OR GLIOBLASTOMA [O] . Matthias Holdhoff, Martin Nicholas, Richard Peterson, 2019

机译：ACTR-63。促进酶活性化合物-1（PAC-1）的I级剂量升级研究与患者反复性包放星形细胞瘤或胶质母细胞瘤的患者组合
7. Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies [O] . Glen J. Weiss, Jeffrey R. Infante, E. Gabriela Chiorean, 2011

机译：第1期关于先进固体恶性肿瘤患者的缺氧活化前药的安全性，耐受性和药代动力学的研究
8. Study of Home Drinking Water Treatment Units Containing Activated Carbon for Organics Reduction: Interim Phase 2 Report to Criteria and Standards Division, Office of Drinking Water [R] . 1980

机译：含活性炭的家庭饮用水处理装置减少有机物的研究：饮用水办公室标准和标准部的第2阶段中期报告

Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies

著录项

相似文献

相关主题

期刊订阅